ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,836Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 1895

$1.45M Total Retail Price of All Prescriptions

Rank: 21 out of 1895

778 Patients Receiving at Least One Drug in Part D
24% Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 778 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

N/A

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$123 was the average price of a prescription from this provider, compared to $121 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
BENZTROPINE MESYLATE 767 176 144 R 1 6
RISPERIDONE 750 156 122 A 2 2
CLONAZEPAM 678 68 106 B 3 3
QUETIAPINE FUMARATE 571 81 95 A 4 1
LORAZEPAM 518 102 108 B 5 5
OLANZAPINE 507 124 76 A 6 7
DIVALPROEX SODIUM 478 119 95 7 20
ABILIFY 443 74 83 A 8 8
ZOLPIDEM TARTRATE 432 92 79 9 11
TRAZODONE HCL 350 81 59 10 4
FLUOXETINE HCL 335 88 62 11 10
ZIPRASIDONE HCL 307 84 50 A 12 28
ALPRAZOLAM 287 66 39 B 13 22
BUPROPION XL 272 50 47 14 19
CLOZAPINE 248 11 25 A 15 16
LITHIUM CARBONATE 226 48 44 16 23
DIVALPROEX SODIUM ER 197 18 40 17 17
HALOPERIDOL 183 40 47 A 18 26
SERTRALINE HCL 179 41 38 19 9
ESCITALOPRAM OXALATE 172 35 35 20 14
MIRTAZAPINE 168 59 34 21 18
CYMBALTA 161 42 32 22 15
DIAZEPAM 160 50 31 B 23 38
CITALOPRAM HBR 140 54 24 24 12
TEMAZEPAM 128 13 49 B 25 31
LATUDA 127 <11 26 A 26 36
CARBAMAZEPINE 126 28 20 27 49
AMPHETAMINE SALT COMBO 118 24 21 S2 28 52
GABAPENTIN 112 <11 24 29 30
VENLAFAXINE HCL ER 110 60 18 30 21
PAROXETINE HCL 102 22 19 31 24
LAMOTRIGINE 93 0 22 32 13
FLUPHENAZINE HCL 91 31 19 A 33 42
CHLORPROMAZINE HCL 84 12 11 A 34 50
INVEGA 75 0 13 A 35 48
BUSPIRONE HCL 74 16 14 36 29
TOPIRAMATE 74 <11 15 36 32
TRIHEXYPHENIDYL HCL 71 <11 <11 R 38 37
OLANZAPINE ODT 69 <11 11 A 39 40
PROPRANOLOL HCL 67 0 14 40 41
FLUVOXAMINE MALEATE 66 24 13 41 57
DONEPEZIL HCL 63 <11 <11 42 33
BUPROPION HCL SR 60 0 12 43 25
IMIPRAMINE HCL 58 <11 15 R 44 92
CLOZAPINE ODT 57 <11 <11 A 45 79
THIOTHIXENE 57 <11 <11 A 45 73
AMITRIPTYLINE HCL 52 <11 11 R 47 54
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.